Acetaminophen: Pathology and clinical presentation of hepatotoxicity

Drug-Induced Liver Disease, Second Edition

Volumn , Issue , 2007, Pages 389-405

  Lee, William M ^a   Ostapowicz, George ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882528592     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (113)

1. Proceedings of the FDA NDAC meeting September 19, 2002. Testimony of Parivash Nourjah, Ph.D. www.fda.gov/ohrms/dockets/ac/cder02.htm#
2. Larson AM, Fontana RJ, Davern TJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 2005; 42:1364-72.
3. Proceedings of the NDAC meeting: Introduction by Charles E. Ganley, M.D. www.fda.gov/ohrms/dockets/ac/cder02.htm#Nonprescription Drugs
4. Davidson DG, Eastham WN. Acute liver necrosis following overdose of paracetamol. Br Med J 1966; 2:497-9.
5. Thompson JS, Prescott LF. Liver damage and impaired glucose tolerance after paracetamol overdose. Brit Med J 1966; 2:506-7.
6. McJunkin B, Barwick KW, Little WC, Winfield JB. Fatal massive hepatic necrosis following acetaminophen overdose. JAMA 1976; 236:1874-5.
7. Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998; 27:1050-5.
8. Gunnell D, Hawton K, Murray V, et al. Use of paracetamol for suicide and non-fatal poisoning in the U.K. and France: are restrictions on availability justified? J Epidemiol Community Health 1997; 51:175-9.
9. Whitcomb DC, Block GD. Association of acetaminophen hepatotoxicity with fasting and alcohol use. JAMA 1994; 272:1845-50.
10. Denison H, Kaczynski J, Wallerstedt S. Paracetamol medication and alcohol abuse: a dangerous combination for the liver and the kidney. Scand J Gastroenterol 1987; 22:701-4.
11. Zimmermann HJ, Maddrey WC. Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 1995; 22:767-73.
12. Shayiq RM, Roberts DW, Rothstein K, et al. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury. Hepatology 1999; 29:451-63.
13. Prescott LF, Critchley JA. The treatment of acetaminophen poisoning. Annu Rev Pharmacol Toxicol 1983; 23:87-101.
14. Hamlyn AN, Douglas AP, James O. The spectrum of paracetamol (acetaminophen) overdose: clinical and epidemiological studies. Postgrad Med J 1978; 54:400-4.
15. Rumack BH. Acetaminophen overdose in young children. Am J Dis Child 1984; 138:428-33.
16. Miller RP, Roberts RJ, Fischer LJ. Acetaminophen elimination kinetics in neonates, children, and adults. Clin Pharmacol Ther 1976; 19:284-94.
17. McClain CJ, Kromhout JP, Peterson FJ, Holtzman JL. Potentiation of acetaminophen hepatotoxicity by alcohol. JAMA 1980; 244:251-3.
18. Seeff LB, Cuccherini BA, Zimmerman HJ, Adler E, Benjamin SB. Acetaminophen hepatotoxicity in alcoholics: a therapeutic misadventure. Ann Intern Med 1986; 104:399-404.
19. Lesser PB, Vietti MM, Clark WD. Lethal enhancement of therapeutic doses of acetaminophen by alcohol. Dig Dis Sci 1986; 3:103-5.
20. Wootton FT, Lee WM. Acetaminophen hepatotoxicity in the alcoholic. South Med J 1990; 83:1047-9.
21. Johnston SC, Pelletier LL. Enhanced hepatotoxicity of acetaminophen in the alcoholic patient: two case reports and a review of the literature. Medicine 1997; 76:185-91.
22. Girre C, Hispard E, Palombo S, N’Guyen C, Dally S. Increased metabolism of acetaminophen in chronically alcoholic patients. Alcohol Clin Exp Res 1993; 17:170-3.
23. Bray GP, Mowat C, Muir DF, Tredger JM, Williams R. The effect of chronic alcohol intake on prognosis and outcome in paracetamol overdose. Hum Exp Toxicol 1991; 10:435-8.
24. Thummel KE, Slattery JT, Ro H, et al. Ethanol exposure and acetaminophen hepatotoxicity:inhibition and induction of hepatotoxic metabolite formation. Clin Pharmacol Ther 2000; 67:5991-9.
25. Prescott LF. Paracetamol, alcohol and the liver. Br J Clin Pharmacol 2000; 49:291-301.
26. Bonkovsky HL, Kane RE, Jones DP, Galinsky RE, Banner B. Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency. Hepatology 1994; 19:1141-8.
27. Pirotte JH. Apparent potentiation of hepatotoxicity from small doses of acetaminophen by phenobarbital. Ann Intern Med 1984; 101:403.
28. McClements BM, Hyland M, Callender ME, Blair TL. Management of paracetamol poisoning complicated by enzyme induction due to alcohol or drugs. Lancet 1990; 335:1526.
29. Bray GP, Harrison PM, O’Grady JG, Tredger JM, Williams R. Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum Exp Toxicol 1992; 11:265-70.
30. Murphy R, Swartz R, Watkins PB. Severe acetaminophen toxicity in a patient receiving isoniazid. Ann Intern Med 1990; 113:799-800.
31. Crippin JS. Acetaminophen hepatotoxicity: potentiation by isoniazid. Am J Gastroenterol 1993; 88:590-2.
32. Shriner K, Goetz MB. Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine. Am J Med 1992; 93:94-6.
33. Schiødt FV, Rochling FA, Casey DL, Lee WM. Acetaminophen toxicity in an urban county hospital. N Engl J Med 1997; 337:1112-7.
34. Schiødt FV, Atillasoy E, Shakil AO, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5:29-34.
35. Ostapowicz GA, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:945-54.
36. Lee WM. Sounding board: acetaminophen hepatotoxicity and the U.S. acute liver failure study:lowering the risks of hepatic failure. Hepatology 2004; 40:6-9.
37. Kumar S, Rex DK. Failure of physicians to recognize acetaminophen hepatotoxicity in chronic alcoholics. Arch Intern Med 1991; 151:1189-91.
38. Rumack BH, Peterson RG. Acetaminophen overdose: incidence, diagnosis and management in 416 patients. Pediatrics 1978; 62:898-903.
39. Rivera-Penera T, Gugig R, Davis J, et al. Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr 1997; 130:300-4.
40. Heubi JE, Barbacci MB, Zimmerman HJ. Therapeutic misadventures with acetaminophen: hepatotoxicity after multiple doses in children. J Pediatr 1998; 132:22-7.
41. Hynson JL, South M. Childhood hepatotoxicity with paracetamol doses less than 150 mg/kg per day. Med J Aust 1999; 171:497.
42. Miles FK, Kamath R, Dorney SF, Gaskin KJ, O’Loughlin EV. Accidental paracetamol overdosing and fulminant hepatic failure in children. Med J Aust 1999; 171:472-5.
43. Pershad J, Nichols M, King W. “The silent killer”: chronic acetaminophen toxicity in a toddler. Pediatr Emerg Care 1999; 15:43-6.
44. Alander SW, Dowd MD, Bratton SL, Kearns GL. Pediatric acetaminophen overdose: risk factors associated with hepatocellular injury. Arch Pediatr Adolesc Med 2000; 154:346-50.
45. Squires RH, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006; 148:652-8.
46. Alonso EM, Sokol RJ, Hart J, Tyson RW, Narkewicz MR, Whitington PF. Fulminant hepatitis associated with centrilobular hepatic necrosis in young children. J Pediatr 1995; 127:888-94.
47. Bonkowsky HL, Mudge GH, McMurtry RJ. Chronic hepatic inflammation and fibrosis due to low doses of paracetamol. Lancet 1978; 1:1016-8.
48. McBride AJ, Meredith-Smith P. Compound opioid/paracetamol analgesics: misuse and dependence. Br J Clin Pract 1995; 49:268-9.
49. Tredger JM, Thuluvath P, Williams R, Murray-Lyon IM. Metabolic basis for high paracetamol dosage without hepatic injury: a case study. Hum Exp Toxicol 1995; 14:8-12.
50. Hawton K, Fagg J. Trends in deliberate self poisoning and self injury in Oxford, 1976-90. Br Med J 1992; 304:1409-11.
51. Litovitz TL, Klein-Schwartz W, White S, et al. 1999 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2000; 18:517-74.
52. Fagan E, Wannan G. Reducing paracetamol overdoses. Br Med J 1996; 313:1417-8.
53. Gilbertson RJ, Harris E, Pandey SK, Kelly P, Myers W. Paracetamol use, availability, and knowledge of toxicity among British and American adolescents. Arch Dis Child 1996; 75:194-8.
54. Prince MI, Thomas SH, James OF, Hudson M. Reduction in incidence of severe paracetamol poisoning. Lancet 2000; 355:2047-8.
55. Turvill JL, Burroughs AK, Moore KP. Change in occurrence of paracetamol overdose in U.K. after introduction of blister packs. Lancet 2000; 355:2048-9.
56. Bernal W. Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 2003; 23:227-37.
57. Hawton K, Townsend E, Deeks J, et al. Effects of legislation restricting packsizes of paracetamol and salicylate poisoning in the United Kingdom before and after stud. Br Med J 2001; 322:1203-7.
58. Sheen C, Dillon J, Bateman D, et al. Paracetamol pack size restriction: the impact on paracetamol poisoning and over-the-counter supply of paracetamol, aspirin and ibuprofen. Pharmacoepidemiol Drug Saf 2002; 11:329-31.
59. Robinson D, Smith AM, Johnston GD. Severity of overdose after restriction of paracetamol availability: retrospective study. Br Med J 2000; 321:926-7.
60. Hawton K, Simkin S, Deeks J, et al. U.K. legislation on analgesic packs: before and after study of long term effect on poisonings. Br Med J 2004; 329:1076.
61. Rumack BH. Acetaminophen overdose. Am J Med 1983; 75:104-12.
62. Portmann B, Talbot IC, Day DW, Davidson AR, Murray-Lyon IM, Williams R. Histopathological changes in the liver following a paracetamol overdose: correlation with clinical and biochemical parameters. J Pathol 1975; 117:169-81.
63. Harrison PM, O’Grady JO, Keays RT, Alexander GJ, Williams R. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. Br Med J 1990; 301:964-6.
64. Schiødt FV, Lee WM. Management of acetaminophen toxicity. In: Krawitt EL, ed. Medical Management of Liver Disease. New York: Marcel Dekker, 1999:325-77.
65. Cobden I, Record CO, Ward MK, Kerr DN. Paracetamol-induced acute renal failure in the absence of fulminant liver damage. Br Med J 1982; 284:21-2.
66. Kaysen GA, Pond SM, Roper MH, Menke DJ, Marrama MA. Combined hepatic and renal injury in alcoholics during therapeutic use of acetaminophen. Arch Intern Med 1985; 145:2019-23.
67. Blakely P, McDonald BR. Acute renal failure due to acetaminophen ingestion: a case report and review of the literature. J Am Soc Nephrol 1995; 6:48-53.
68. Wendon JA, Ellis AJ. Circulatory derangements, monitoring and management: heart, kidney and brain. In: Lee WM, Williams R, eds. Acute Liver Failure. Cambridge, MA: Cambridge University Press, 1997:132-43.
69. Dawson DJ, Babbbs C, Warnes TW, Neary RH. Hypophosphatemia in acute liver failure. Br Med J 1987; 295:1312-3.
70. Jones AF, Harvey JM, Vale JA. Hypophosphatemia and phosphaturia in paracetamol poisoning. Lancet 1989; 2:608-9.
71. Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminopheninduced hepatotoxicity. Hepatology 2002; 36:659-65.
72. Chung PY, Sitrin MD, Te HS. Serum phosphorus levels predict clinical outcome in fulminant hepatic failure. Liver Transpl 2003; 9:248-53.
73. Davern TJ, Polson J, Lalani E, Lee WM. The U.S. ALF Study Group. Serum phosphate levels as a predictor of clinical outcome in acetaminophen induced acute liver failure. Hepatology 2003; 38:212A.
74. O’Grady J, Alexander GJM, Hayallar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439-45.
75. Muldrew KL, James LP, Coop L, et al. Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxic doses of acetaminophen using highperformance liquid chromatography with electrochemical detection. Drug Metab Dispos 2002; 30:446-51.
76. James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 2003; 31:1499-506.
77. Davern TJ, II, James LP, Hinson JA, et al. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology 2006; 130:687-94.
78. James LP, Alonso E, Hynan L, et al. Detection of acetaminophen adducts in children with acute liver failure of indeterminate etiology. Pediatrics 2006; 118:e676-81.
79. Polson J, James LP, Davern TJ, et al. Acetaminophen as a co-factor in acute liver failure due to viral hepatitis determined by measurement of acetaminophen-protein adducts. Gastroenterology 2006; 130(Suppl. 4):772.
80. Clark R, Borirakchanyavat V, Davidson AR, et al. Hepatic damage and death from overdose of paracetamol. Lancet 1973; 1:66-70.
81. Wakeel RA, Davies HT, Williams JD. Toxic myocarditis in paracetamol poisoning. Br Med J 1987; 295:1097.
82. Mann JM, Peirre-Louis M, Kragel PJ, Kragel AH, Roberts WC. Cardiac consequences of massive acetaminophen overdose. Am J Cardiol 1989; 63:1018-21.
83. Weston MJ, Talbot IC, Howorth PJN, Mant AK, Capildeo R, Williams R. Frequency of arrhythmias and other cardiac abnormalities in fulminant hepatic failure. Br Heart J 1976; 38:1179-88.
84. Amour A, Slater SD. Paracetamol cardiotoxicity. Postgrad Med J 1993; 69:52-4.
85. Jones AL. Unusual complications of paracetamol poisoning. Q J Med 1997; 90:161-8.
86. Broughan TA, Soloway RD. Acetaminophen hepatotoxicity. Dig Dis Sci 2000; 45:1553-8.
87. Brotodihardjo AE, Batey RG, Farrell GC, Byth K. Hepatotoxicity from paracetamol self-poisoning in western Sydney: a continuing challenge. Med J Aust 1992; 157:382-5.
88. Gow PJ, Smallwood RA, Angus PW. Paracetamol overdose in a liver transplant centre: an 8-year experience. J Gastroenterol Hepatol 1999; 14:817-21.
89. Buckley NA, Whyte IM, O’Connell DL, Dawson AH. Oral or intravenous N-acetylcysteine: which is the treatment of choice for acetaminophen (paracetamol) poisoning? Clin Toxicol 1999; 37:759-67.
90. Lee WM, Schiødt FV. Fulminant hepatic failure. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff’s Textbook of Liver Diseases. New York: Lippincott-Raven, 1999:879-98.
91. Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975; 55:871-6.
92. Underhill TJ, Greene MK, Dove AF. A comparison of the efficacy of gastric lavage, ipecacuanha and activated charcoal in the emergency management of paracetamol overdose. Arch Emerg Med 1990; 7:148-54.
93. Bridger S, Henderson K, Glucksman E, Ellis AJ, Henry JA, Williams R. Deaths from low dose paracetamol poisoning. Br Med J 1998; 316:1724-5.
94. Bertholf RL, Johannsen LM, Bazooband A, Mansouri V. False positive acetaminophen results in a hyperbilirubinemic patient. Clin Chem 2003; 49:695-8.
95. Beuhler MC, Curry SC. False positive acetaminophen levels associated with hyperbilirubinemia. Clin Toxicol 2005; 43:167-70.
96. Polson J, Orsulak P, Wians F, et al. Elevated bilirubin may cause false positive acetaminophen levels in hepatitis patients. Hepatology 2004; 40:496A.
97. Spiller HA, Krenzelok EP, Grande GA, Safir EF, Diamond JJ. A prospective evaluation of the effect of activated charcoal before oral N-acetylcysteine in acetaminophen overdose. Ann Emerg Med 1994; 23:519-23.
98. Lauterburg BH, Corcoran GB, Mitchell JR. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest 1983; 71:980-91.
99. Huggett A, Blair IA. The mechanism of paracetamol-induced hepatotoxicity: implications for therapy. Hum Toxicol 1983; 2:399-405.
100. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324:1852-7.
101. Peristeris P, Clark BD, Gatti S, et al. N-Acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol 1992; 140:390-9.
102. Henderson A, Hayes P. Acetylcysteine as a cytoprotective antioxidant in patients with severe sepsis:potential new use for an old drug. Ann Pharmacother 1994; 28:1086-98.
103. Harrison P, Wendon J, Williams R. Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology 1996; 23:1067-72.
104. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988; 319:1557-62.
105. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. Br Med J 1979; 2:1097-100.
106. Smilkstein MJ, Bronstein AC, Linden C, Augenstein WL, Kulig KW, Rumack BH. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine treatment protocol. Ann Emerg Med 1991; 20:1058-63.
107. Bailey B, Amre DK, Gaudreault P. Fulminant hepatic failure secondary to acetaminophen poisoning:a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 2003; 31:299-305.
108. Harrison PM, Keays R, Bray GP, Alexander GJ, Williams R. Improved outcome of paracetamolinduced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990; 335:1572-3.
109. Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. Br Med J 1991; 303:1026-9.
110. Dawson AH, Henry DA, McEwen J. Adverse reactions to N-acetylcysteine during treatment for paracetamol poisoning. Med J Aust 1989; 150:329-31.
111. Lee WM. Medical management of acute liver failure. In: Lee WM, Williams R, eds. Acute Liver Failure. Cambridge, MA: Cambridge University Press, 1997:115-31.
112. Polson J, Lee WM. AASLD position paper: acute liver failure. Hepatology 2005; 41:1179-97.
113. Shakil AO, Kramer D, Mazariegos GV, Funn JJ, Rakela J. Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000; 6:163-9.